3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
631
Head and Neck Neoplasms
614
Carcinoma, Non-Small-Cell Lung
200
Thyroid Neoplasms
198
Melanoma
146
Nasopharyngeal Carcinoma
133
Oropharyngeal Neoplasms
130
Colorectal Neoplasms
128
Mouth Neoplasms
126
Neoplasms
115
Breast Neoplasms
113
Lung Neoplasms
108
Ovarian Neoplasms
105
Uterine Cervical Neoplasms
100
Neoplasm Metastasis
94
Carcinoma, Squamous Cell
85
Stomach Neoplasms
82
Carcinoma, Renal Cell
82
Triple Negative Breast Neoplasms
76
Pancreatic Neoplasms
72
Laryngeal Neoplasms
68
Esophageal Neoplasms
68
Endometrial Neoplasms
66
Urinary Bladder Neoplasms
59
Sarcoma
57
Thyroid Cancer, Papillary
54
Prostatic Neoplasms
53
Salivary Gland Neoplasms
49
Carcinoma, Transitional Cell
47
Carcinoma, Hepatocellular
45
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bronchial Diseases
×
Head & Neck
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts